Skip to main content

Aclipse Therapeutics

Radnor, United States

Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.

$1.5M raised
Apr 2022
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aclipse Therapeutics

How much funding has Aclipse Therapeutics raised?
Aclipse Therapeutics has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Who are Aclipse Therapeutics's investors?
Aclipse Therapeutics's investors include U.S. Department of War, Medical Research Council, Intellectual Digital Global (iDG), FightMND, Intellectual Digital Corp. (iDC).
Where is Aclipse Therapeutics headquartered?
Aclipse Therapeutics is headquartered in Radnor, United States.
What does Aclipse Therapeutics do?
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
What stage is Aclipse Therapeutics at?
Aclipse Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aclipse Therapeutics — Funding & Investors." VCBacked, April 20, 2022, https://www.vcbacked.co/company/aclipse-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Aclipse Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aclipse-therapeutics
Wikipedia (cite web)
{{cite web |title=Aclipse Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aclipse-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .